The researchers believe there are other disease entities, aside from cancers, that may be significantly affected by
targeted epigenetic therapies.
Not exact matches
«These new insights into the complexities of
epigenetic regulation are contributing to our basic understanding of this process in human health and disease and gives us new vision for how to go about
targeting errors in DNA methylation with innovative drug
therapies.»
The current study was designed to clarify the cellular hierarchy underlying glioblastoma, to identify
epigenetic factors that distinguish glioblastoma stem cells from more differentiated tumor cells and to suggest potential
therapies targeting those factors.
«It is expected that this study will lay the foundation for developing a new class of potent and effective cancer
therapies and the development of reagents
targeting epigenetic events in immune - mediated diseases as well as other epigenetically - influenced diseases,» said Alani, who also is chief of dermatology at Boston Medical Center.
The proposed strategy reflects a continuing move toward combination
therapies, particularly when it comes to
epigenetic approaches, which
target the mechanisms that control whether genes are switched «on» or «off.»
The researchers were able to reverse these
epigenetic changes with the use of an FDA - approved drug, forcing the cancer cells out of hiding and potentially making them better
targets for the same immune
therapy that in the past may have failed.
«Multiple
epigenetic regulators participate in the drug - desensitizing pathway, so they could serve as new
targets to improve
therapy for this type of cancer.»
Understanding these pathways, and the identification of the key proteins that control the ability of cancer cells to reprogram their metabolism through biochemical, and
epigenetic or genetic alterations that make them resistant to
therapies, is of paramount importance for the design of more
targeted and therefore less toxic
therapies.
For example, the discovery of cancer - causing genetic and
epigenetic changes in tumors has enabled the development of
therapies that
target these changes as well as diagnostic tests that identify patients who may benefit from these
therapies.
Increased understanding of
epigenetic disease mechanisms, including natural and anthropogenic environment factors, could lead to disease risk stratification for
targeted intervention and to
targeted therapies.
Increased understanding of
epigenetic disease mechanisms could lead to disease risk stratification for
targeted intervention and to
targeted therapies [6].
Epigenetic Therapy A novel two - drug treatment targets epigenetic alterations that help give cancer cells t
Epigenetic Therapy A novel two - drug treatment
targets epigenetic alterations that help give cancer cells t
epigenetic alterations that help give cancer cells their edge.
In particular, Dr. Azad's laboratory and clinical trials explore
epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly
targeted drugs.
Understanding
epigenetic mechanisms and their contribution to the persistence of diabetic complications is critical because it could suggest alternative
targets for
therapy to halt and reverse complications.
«This offers the opportunity for development of
epigenetic targeted therapies for patients with ALL that could be broadly applicable to many patients.»